MAPK3 and schwannoma: Treatment of human schwannoma cells in vitro with curcumin (diferuloylmethane), caused dephosphorylation of AKT and ERK1/2 and activation of the merlin phosphatase MYPT1-pp1δ, which is responsible for the dephosphorylation of S518 [76].